Media formats available:
Recommended
- Redefining intensive LDL-c management in high CV risk patients - The case for combination therapyCombination therapy with PCSK9 mAbs in post-MI patients
Derek Connolly, MD, PhD
- Redefining intensive LDL-c management in high CV risk patients - The case for combination therapyChanging the paradigm on LDL-c-lowering in high CV risk patients
Prof Kausik Ray